Clariant, CH0012142631

Clariant stock weighs Q3 margin pressure against steady guidance

Published on 11/03/2026 at 18:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Clariant stock faces lower quarterly profitability despite stronger sales. Management kept its 2026 outlook as Catalysts remained under pressure.

Quarterly growth meets margin pressure

  • Third-quarter sales rose 5.6 percent in local currencies to CHF 968.8 million.
  • EBITDA before exceptional items fell 6.5 percent, while the margin declined to 15.6 percent.
  • Clariant kept its 2026 guidance and targets CHF 90 million in run-rate savings.
Clariant, CH0012142631, Illustration mit AI erstellt.

Clariant reported stronger third-quarter sales on Tuesday, November 3, 2026, but profitability weakened as margin pressure and geopolitical disruption weighed on the specialty chemicals group. The company said in an announcement published by GlobeNewswire that third-quarter sales rose 5.6 percent in local currencies to CHF 968.8 million.

Sales growth offsets weaker margins

Pricing increased 5.7 percent across the group, while volumes were broadly flat after portfolio pruning. Care Chemicals sales gained 6.6 percent in local currencies, and Adsorbents & Additives sales increased 6.4 percent.

Adjusted EBITDA fell 6.5 percent year on year to CHF 151.5 million. The corresponding margin declined to 15.6 percent from 17.9 percent, reflecting the normalization of a prior-year corporate cost effect, a less favorable mix and volatile raw materials affecting costs and inventory valuation.

Catalysts remained the main operating pressure point. Sales increased 1.8 percent in local currencies, but volumes declined 1.9 percent as customers delayed orders amid the continuing conflict in the Middle East. The unit's adjusted EBITDA fell 29.4 percent to CHF 23.1 million.

Guidance remains tied to fourth quarter

Clariant kept its full-year 2026 outlook unchanged. The company continues to expect sales in local currencies to remain broadly flat and an EBITDA margin before exceptional items of around 18 percent. Management pointed to a strong fourth-quarter order book, particularly in Catalysts, while warning that geopolitical and cost pressures remain.

Performance-improvement programs generated CHF 79 million in run-rate savings through the first nine months, including CHF 10 million in the third quarter. Clariant remains on track for CHF 90 million in savings for 2026 and CHF 100 million by 2027. Nine-month sales rose 1.0 percent in local currencies to CHF 2.8281 billion, while the adjusted EBITDA margin fell to 17.1 percent.

Quote and investor context

Clariant stock traded at 11.51 euros on Lang & Schwarz at 6:29:48 p.m. CET on Tuesday, November 3, 2026. The real-time quote of Clariant stock gives investors a current trading reference after the quarterly release.

Clariant stock at a glance

  • Company: Clariant AG
  • ISIN: CH0012142631
  • Lang & Schwarz quote: 11.51 euros on November 3, 2026, at 6:29:48 p.m. CET
  • Q3 sales: CHF 968.8 million
  • Adjusted EBITDA: CHF 151.5 million

The Swiss Market Index provides the broader market backdrop for Swiss equities.

More news and analyses on Clariant stock

Disclaimer...
en | CH0012142631 | CLARIANT | boerse | 70452181 |